Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bioscrip Inc (BIOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 237,087
  • Shares Outstanding, K 128,155
  • Annual Sales, $ 708,900 K
  • Annual Income, $ -51,690 K
  • 60-Month Beta 0.69
  • Price/Sales 0.33
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.12
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.14
  • Prior Year -0.12
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.56 +19.22%
on 04/23/19
2.12 -12.25%
on 03/26/19
-0.24 (-11.44%)
since 03/25/19
3-Month
1.56 +19.22%
on 04/23/19
3.87 -51.88%
on 02/05/19
-1.79 (-49.05%)
since 01/25/19
52-Week
1.56 +19.22%
on 04/23/19
4.14 -55.08%
on 12/13/18
-0.84 (-31.12%)
since 04/25/18

Most Recent Stories

More News
BioScrip, Inc. Provides Merger Update

BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today provided an update on its proposed merger with...

BIOS : 1.86 (+0.54%)
OPTN : 8.89 (-10.56%)
Moving Average Crossover Alert: BioScrip

BioScrip, Inc. (BIOS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

BIOS : 1.86 (+0.54%)
Why Is BioScrip (BIOS) Down 50.4% Since Last Earnings Report?

BioScrip (BIOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BIOS : 1.86 (+0.54%)
New Strong Sell Stocks for April 11th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

CCRN : 6.98 (-1.69%)
BIOS : 1.86 (+0.54%)
GLOP : 20.64 (+1.98%)
ENT : 0.66 (-14.29%)
GARS : 7.12 (unch)
New Strong Sell Stocks for April 9th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

CBPO : 99.97 (+0.21%)
AMEH : 19.62 (+0.51%)
CCRN : 6.98 (-1.69%)
BIOS : 1.86 (+0.54%)
CNTY : 9.09 (+0.55%)
New Research Coverage Highlights Washington Real Estate Investment Trust, Spark Energy, American Midstream Partners, LP, Ring Energy, BioScrip, and RCI Hospitality -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Washington Real Estate Investment...

SPKE : 9.23 (-1.91%)
BIOS : 1.86 (+0.54%)
REI : 5.34 (+0.75%)
AMID : 5.20 (-0.19%)
RICK : 22.84 (-0.44%)
WRE : 28.02 (-1.51%)
New Strong Sell Stocks for April 1st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

CRON : 16.44 (-0.90%)
DF : 1.72 (-6.01%)
BGG : 13.87 (-1.21%)
BIOS : 1.86 (+0.54%)
CSBR : 8.55 (+1.30%)
BioScrip (BIOS) Reports Loss in Q4, Both Margins Contract

The combined expertise of BioScrip (BIOS) and OptionCare is expected to drive significant growth for the former.

BIOS : 1.86 (+0.54%)
ABMD : 266.60 (-1.56%)
VAR : 131.63 (-1.23%)
CNMD : 81.16 (+1.44%)
Do Options Traders Know Something About BioScrip (BIOS) Stock We Don't?

Investors need to pay close attention to BioScrip (BIOS) stock based on the movements in the options market lately.

BIOS : 1.86 (+0.54%)
BioScrip, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 15, 2019 / BioScrip, Inc. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 15, 2019, 2018 at 9:00 AM Eastern...

BIOS : 1.86 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade BIOS with:

Business Summary

BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas:...

See More

Key Turning Points

2nd Resistance Point 1.94
1st Resistance Point 1.89
Last Price 1.86
1st Support Level 1.79
2nd Support Level 1.73

See More

52-Week High 4.14
Fibonacci 61.8% 3.15
Fibonacci 50% 2.85
Fibonacci 38.2% 2.55
Last Price 1.86
52-Week Low 1.56

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar